Utility and evaluation of immunohistochemical detection of BRAF V600E mutation in melanoma
10.3760/cma.j.issn.0529-5807.2017.08.006
- VernacularTitle: BRAF V600E抗体在检测恶性黑色素瘤BRAF V600E基因突变中的应用价值
- Author:
Jiaojie LYU
1
;
Yunyi KONG
;
Xu CAI
;
Xuxia SHEN
;
Yawen LU
;
Min REN
Author Information
1. Department of Pathology, Shanghai Cancer Center, Fudan University and Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China
- Publication Type:Journal Article
- Keywords:
Melanoma;
Proto-oncogene proteins B-raf;
Mutation;
Immunohistochemistry
- From:
Chinese Journal of Pathology
2017;46(8):548-552
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To evaluate the sensitivity, specificity and clinical value of anti-BRAF V600E antibody (clone VE1) in detection of the BRAF V600E mutant in formalin-fixed and paraffin-embedded (FFPE) melanoma specimens by immunohistochemical (IHC) methods.
Methods:A total of 50 melanoma samples collected between 2008 and 2016 from 40 patients were analyzed for BRAF mutation (exon 15) by DNA sequencing using FFPE. These tissues were immunostained with VE1 antibody, and the results were analyzed and compared with those by DNA sequencing.
Results:By DNA sequencing, 36 cases showed BRAF mutation while others were BRAF wild type. Among the 36 cases with BRAF mutation, 32 harbored BRAF V600E, two harbored BRAF V600K, one had BRAF K601E and one had BRAF D594N, respectively. IHC staining showed 30 specimens were VE1 positive, while 19 were negative. The determination of IHC result for one case was obscured by heavy pigments. Of the BRAF-mutated specimens, four specimens with BRAF mutation other than V600E were all negative for VE1. The sensitivity and specificity of the VE1 immunostaining was 96.8% and 100.0% respectively.Concordance of BRAF V600E detection between immunostaining and DNA sequencing was 98.0%(48/49).
Conclusions:High sensitivity and specificity for VE1 immunostaining in detecting BRAF V600E in melanomas are demonstrated. It is a rapid and cost-effective method for detecting BRAF V600E mutations in melanoma patients. Hence, VE1 immunostaining can be used as an important screening method for BRAF mutation in laboratories.
